| Primary |
| Asthma |
36.0% |
| Product Used For Unknown Indication |
32.0% |
| Chronic Obstructive Pulmonary Disease |
8.0% |
| Dyspnoea |
8.0% |
| Respiratory Disorder |
8.0% |
| Bronchitis |
4.0% |
| Cough |
4.0% |
|
| Myocardial Infarction |
12.0% |
| Pneumonia |
12.0% |
| Hospitalisation |
8.0% |
| Asthma |
4.0% |
| Coronary Artery Occlusion |
4.0% |
| Death |
4.0% |
| Drug Effect Decreased |
4.0% |
| Dyspnoea |
4.0% |
| Foreign Body |
4.0% |
| Malaise |
4.0% |
| Medication Error |
4.0% |
| Memory Impairment |
4.0% |
| Oral Candidiasis |
4.0% |
| Oropharyngeal Pain |
4.0% |
| Pain |
4.0% |
| Pain In Extremity |
4.0% |
| Pharyngitis |
4.0% |
| Road Traffic Accident |
4.0% |
| Steroid Withdrawal Syndrome |
4.0% |
| Surgery |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
37.6% |
| Asthma |
9.1% |
| Pneumonia |
9.1% |
| Emphysema |
7.3% |
| Respiratory Failure |
7.3% |
| Anxiety |
3.0% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Urinary Tract Infection |
3.0% |
| Depression |
2.4% |
| Sinus Disorder |
2.4% |
| Upper Respiratory Tract Infection |
2.4% |
| Bronchitis |
1.8% |
| Diverticulitis |
1.8% |
| Infection |
1.8% |
| Multiple Sclerosis |
1.8% |
| Blood Cholesterol Increased |
1.2% |
| Blood Pressure Abnormal |
1.2% |
| Breakthrough Pain |
1.2% |
| Chemotherapy |
1.2% |
| Cough |
1.2% |
|
| Tenosynovitis |
15.6% |
| Stomatitis |
12.5% |
| Urticaria |
9.4% |
| Drug Hypersensitivity |
6.3% |
| Flatulence |
6.3% |
| Pyrexia |
6.3% |
| Adrenal Suppression |
3.1% |
| Cardiac Failure Congestive |
3.1% |
| Death |
3.1% |
| Dyspnoea |
3.1% |
| Nausea |
3.1% |
| Pneumonia |
3.1% |
| Psychomotor Hyperactivity |
3.1% |
| Restless Legs Syndrome |
3.1% |
| Tendonitis |
3.1% |
| Trigger Finger |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Urinary Tract Infection |
3.1% |
| Urinary Tract Infection Staphylococcal |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.0% |
| Asthma |
14.2% |
| Chronic Obstructive Pulmonary Disease |
10.6% |
| Hypertension |
6.0% |
| Pain |
5.9% |
| Depression |
3.6% |
| Drug Use For Unknown Indication |
3.5% |
| Dyspnoea |
2.7% |
| Diabetes Mellitus |
2.6% |
| Atrial Fibrillation |
2.3% |
| Cardiac Disorder |
2.3% |
| Rheumatoid Arthritis |
2.1% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Anxiety |
1.8% |
| Pulmonary Arterial Hypertension |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Insomnia |
1.5% |
| Multiple Sclerosis |
1.5% |
| Crohn's Disease |
1.5% |
| Osteoporosis |
1.5% |
|
| Pulmonary Embolism |
11.2% |
| Vomiting |
11.2% |
| Wheezing |
9.7% |
| Pain |
9.2% |
| Weight Decreased |
7.3% |
| Death |
6.3% |
| Product Quality Issue |
4.4% |
| Myocardial Infarction |
3.9% |
| Urticaria |
3.9% |
| Nausea |
3.4% |
| Pain In Extremity |
3.4% |
| Pneumonia |
3.4% |
| Pyrexia |
3.4% |
| Weight Increased |
3.4% |
| Drug Ineffective |
2.9% |
| Respiratory Failure |
2.9% |
| Vision Blurred |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Dyspnoea |
2.4% |
| Off Label Use |
2.4% |
|
